News

medwatch. com
medwatch. com > News > Pharma___Biotech > article19304012. ece

Novo Nordisk faces competition in Canada from Indian semaglutide copy

1+ hour, 29+ min ago  (166+ words) medwatch. com Stay ahead of development by receiving our newsletter on the latest sector knowledge. Laboratory Systems & Digitalization Specialist Director Global Commercial Partnerships Novo Nordisk faces competition in Canada from Indian semaglutide copy The company in question is India's Dr....

Symbols: btc-usd
Ukrainian National News (UNN)
unn. ua > en > news > global-obesity-trends-vary-by-country-age-and-income-level-study

Global obesity trends vary by country, age, and income level " study

1+ hour, 29+ min ago  (708+ words) May 18 2026, 07: 59 AM1116views A study of 200 countries has debunked the myth of a single obesity epidemic. Rates are rising in poor nations, while they have stabilized in wealthy Western countries. Researchers note that the study's results challenge the notion of a single…...

Moomoo
moomoo. com > news > post > 70/14/7740 > hbm-holdings-obesity-drug-found-to-have-favorable-profile-in

HBM Holdings' Obesity Drug Found to Have Favorable Profile in Preclinical Data

7+ hour, 1+ min ago  (13+ words) Moomoo...

Symbols: btc-usd,nyse:lly
European Medical Journal
emjreviews. com > en-us > amj > dermatology > news > scale-2026-glp-1-weight-loss-intensifies-aesthetic-care

GLP-1 Weight Loss and Aesthetic Care - AMJ

7+ hour, 46+ min ago  (16+ words) GLP-1 weight loss may affect skin laxity, muscle tone, and body contouring needs. Read more....

Symbols: glp-1s
Seoul Economic Daily
en. sedaily. com > finance > 05/18/2026 > hanmi-pharmaceutical-expands-obesity-drug-indication-to

Hanmi Pharmaceutical Expands Obesity Drug Indication to Diabetes, Begins Phase 3 Dosing

1+ hour, 40+ min ago  (86+ words) GLP-1 Class Drug 'Efpeglenatide' Phase 3 to Evaluate Combination Therapy's Blood Sugar Control Hanmi Pharmaceutical has begun dosing patients in a domestic Phase 3 clinical trial aimed at expanding the indication of its in-house developed glucagon-like peptide (GLP)-1 class new drug "efpeglenatide…...

Symbols: nyse:lly
Moomoo
moomoo. com > news > post > 70/13/5396 > is-the-weight-loss-drug-revolution-causing-a-frailty-epidemic

Is the Weight-Loss Drug Revolution Causing a Frailty Epidemic? -- WSJ

17+ hour, 22+ min ago  (12+ words) Moomoo...

Symbols: covid-19,btc-usd,eth-usd,acp-im
Mirage News
miragenews. com > why-exercise-alone-often-isnt-enough-for-weight-1675382

Why Exercise Alone Often Isn't Enough For Weight Loss

1+ hour, 4+ min ago  (266+ words) " New international study led by Tel Aviv University explains why exercise alone often leads to limited weight loss. " Researchers found that as physical activity increases, the body adapts by reducing energy expenditure elsewhere. " Participants improved fitness, reduced fat, and gained…...

Mercola. com
articles. mercola. com > sites > articles > archive > 05/18/2026 > ozempic-suicidal-ideation. aspx

Ozempic's Dark Side: 45% Increased Risk of Suicidal Ideation

3+ hour, 29+ min ago  (1594+ words) Semaglutide, marketed as Ozempic and Wegovy, has taken the weight loss world by storm. Originally developed to treat Type 2 diabetes, its dramatic weight loss effects quickly caught attention. However, a study analyzing World Health Organization data raises serious concerns about…...

Symbols: sglt-2,glp-1s,btc-usd,nasdaq:nrxp
The Asia Business Daily
asiae. co. kr > en > article > bio-health > 2026051815493524854

Hanmi Pharmaceutical Begins First Dosing in Phase 3 Diabetes Trial for Obesity Drug Efpeglenatide

2+ hour, 39+ min ago  (105+ words) Published 18 May. 2026 15: 49(KST) Hanmi Pharmaceutical has begun the first dosing in a domestic Phase 3 clinical trial to expand the diabetes indication for its independently developed GLP-1 new drug, efpeglenatide. Exterior view of Hanmi Group headquarters. Hanmi Group On May 18, Hanmi…...

Symbols: nyse:lly
Daily Maverick
dailymaverick. co. za > article > 2026-05-18-no-nonsense-nutrition-a-science-based-plan-to-transform-health

No-Nonsense Nutrition: A science-based plan to transform health

1+ week, 3+ day ago  (419+ words) Clinical nutritionist Dominique Ludwig combines expertise, research and learnings from 30 years of practice with approachable, delicious cooking in her book No-Nonsense Nutrition. In her debut book, clinical nutritionist Dominique Ludwig offers a comprehensive and science-based approach to transforming your health…...

Symbols: btc-usd